Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

kanoncure.com

Founded Year

2016

Stage

Seed VC - III | Alive

About KanonCure

KanonCure is a developer of regenerative medicine for the treatment of liver diseases. The company develops liver cell sheets made of mesenchymal stem cells (MSCs), which can be placed onto liver surfaces to treat acute liver failure and liver fibrosis.

KanonCure Headquarters Location

#604 Tottori Univ. Alesco Bldg. 86 Nishi-cho

Yonago, 683-0826,

Japan

+81-50-6863-4511

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing KanonCure

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

KanonCure is included in 1 Expert Collection, including Regenerative Medicine.

R

Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

KanonCure Patents

KanonCure has filed 5 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Cell biology
  • Stem cells
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/25/2015

1/4/2022

Transcription factors, Clusters of differentiation, Stem cells, Experimental cancer drugs, Oncology

Grant

Application Date

3/25/2015

Grant Date

1/4/2022

Title

Related Topics

Transcription factors, Clusters of differentiation, Stem cells, Experimental cancer drugs, Oncology

Status

Grant

  • When was KanonCure founded?

    KanonCure was founded in 2016.

  • Where is KanonCure's headquarters?

    KanonCure's headquarters is located at #604 Tottori Univ. Alesco Bldg., Yonago.

  • What is KanonCure's latest funding round?

    KanonCure's latest funding round is Seed VC - III.

  • Who are the investors of KanonCure?

    Investors of KanonCure include CYBERDYNE, CEJ Capital, Tottori Capital and JR West Innovations.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.